Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20.

Lactobacillus salivarius Streptococcus mutans haploinsufficiency of A20 inborn errors of immunity intestinal microbiome regulatory T cells

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 01 10 2021
accepted: 28 12 2021
entrez: 14 2 2022
pubmed: 15 2 2022
medline: 6 4 2022
Statut: epublish

Résumé

Haploinsufficiency of A20 (HA20) is a form of inborn errors of immunity (IEI). IEIs are genetically occurring diseases, some of which cause intestinal dysbiosis. Due to the dysregulation of regulatory T cells (Tregs) observed in patients with HA20, gut dysbiosis was associated with Tregs in intestinal lamina propria. Stool samples were obtained from 16 patients with HA20 and 15 of their family members. Infant samples and/or samples with recent antibiotics use were excluded; hence, 26 samples from 13 patients and 13 family members were analyzed. The 16S sequencing process was conducted to assess the microbial composition of samples. Combined with clinical information, the relationship between the microbiome and the disease activity was statistically analyzed. The composition of gut microbiota in patients with HA20 was disturbed compared with that in healthy family members. Age, disease severity, and use of immunosuppressants corresponded to dysbiosis. However, other explanatory factors, such as abdominal symptoms and probiotic treatment, were not associated. The overall composition at the phylum level was stable, but some genera were significantly increased or decreased. Furthermore, among the seven operational taxonomic units (OTUs) that increased, two OTUs, Detailed interaction on intestinal epithelium remains unknown; the relationship between the disease and stool composition change helps us understand the mechanism of an immunological reaction to microorganisms.

Identifiants

pubmed: 35155270
doi: 10.3389/fcimb.2021.787667
pmc: PMC8834539
doi:

Substances chimiques

RNA, Ribosomal, 16S 0
Tumor Necrosis Factor alpha-Induced Protein 3 EC 3.4.19.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

787667

Informations de copyright

Copyright © 2022 Toyofuku, Takeshita, Ohnishi, Kiridoshi, Masuoka, Kadowaki, Nishikomori, Nishimura, Kobayashi, Ebato, Shigemura, Inoue, Suda, Hattori, Morio, Honda and Kanegane.

Déclaration de conflit d'intérêts

KH is a scientific advisory board member of Vedanta Biosciences and 4BIO CAPITAL. YK is an employee of JSR Corporation. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Gastroenterology. 2015 Jul;149(1):139-50
pubmed: 25982289
DNA Res. 2013 Jun;20(3):241-53
pubmed: 23571675
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Clin Rev Allergy Immunol. 2019 Oct;57(2):145-165
pubmed: 29754192
Nat Commun. 2021 Feb 18;12(1):1139
pubmed: 33602945
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18193-8
pubmed: 17991771
J Exp Med. 2010 Oct 25;207(11):2323-30
pubmed: 20921284
Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):563-570
pubmed: 31389816
PLoS One. 2019 Jul 11;14(7):e0218999
pubmed: 31295268
J Clin Immunol. 2021 Nov;41(8):1954-1956
pubmed: 34427832
J Allergy Clin Immunol. 2019 Feb;143(2):775-778.e6
pubmed: 30312711
Scand J Immunol. 2020 Jan;91(1):e12805
pubmed: 31267543
Mucosal Immunol. 2016 Nov;9(6):1455-1465
pubmed: 26982597
Blood. 2016 Oct 20;128(16):2083-2088
pubmed: 27461930
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3767-3780
pubmed: 34246792
Clin Immunol. 2020 Jul;216:108441
pubmed: 32335289
Front Cell Infect Microbiol. 2020 Nov 24;10:572912
pubmed: 33330122
Pediatr Res. 2022 Jan;91(1):35-43
pubmed: 33731809
Microbiome. 2018 Aug 4;6(1):135
pubmed: 30077182
Dig Liver Dis. 2002 Sep;34 Suppl 2:S12-8
pubmed: 12408433
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
J Allergy Clin Immunol. 2018 Apr;141(4):1485-1488.e11
pubmed: 29241730
Adv Exp Med Biol. 2021;1278:191-203
pubmed: 33523449
Genome Med. 2018 Sep 28;10(1):70
pubmed: 30261899
Front Immunol. 2021 Aug 02;12:712915
pubmed: 34408753
Appl Environ Microbiol. 2001 Sep;67(9):4374-6
pubmed: 11526051
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2567-72
pubmed: 15701695

Auteurs

Etsushi Toyofuku (E)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Kozue Takeshita (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Hidenori Ohnishi (H)

Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.

Yuko Kiridoshi (Y)

JSR-Keio University Medical and Chemical Innovation Center (JKiC), JSR Corporation, Tokyo, Japan.

Hiroaki Masuoka (H)

Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Tomonori Kadowaki (T)

Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.

Ryuta Nishikomori (R)

Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan.
Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.

Kenichi Nishimura (K)

Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Chie Kobayashi (C)

Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Takasuke Ebato (T)

Department of Pediatrics, Kitasato University Hospital, Sagamihara, Japan.

Tomonari Shigemura (T)

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.

Yuzaburo Inoue (Y)

Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.

Wataru Suda (W)

Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Masahira Hattori (M)

Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.

Tomohiro Morio (T)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Kenya Honda (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Hirokazu Kanegane (H)

Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH